Effects of Long-Term, Monthly Administration of the PCSK9 Inhibitor Evolocumab in Patients with Dysglycemia or Metabolic Syndrome
Year: 2014
Type: article
Source: Canadian Journal of Diabetes
Authors: Robert R. Henry, Rury R. Holman, Robert P. Giugliano, Frederick J. Raal, David Sullivan, Narimon Honarpour, Patric Nelson, Mary Elliott, Thomas LIU, Scott M. Wasserman, Michael J. Koren
Institution: University of Oxford
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2070668396
